Dikaliumdihydrogen-15α-hydroxy-2β-[[2-O-isovaleryl-3,4-di-O-sulfonato-β-D-glucopyranosyl]oxy]kaur-16-en-18,19-dioat
|
|
- CAS-Nr.
- 33286-30-5
- Bezeichnung:
- Dikaliumdihydrogen-15α-hydroxy-2β-[[2-O-isovaleryl-3,4-di-O-sulfonato-β-D-glucopyranosyl]oxy]kaur-16-en-18,19-dioat
- Englisch Name:
- dipotassium dihydrogen 15alpha-hydroxy-2beta-[[2-O-isovaleryl-3,4-di-O-sulphonato-beta-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioate
- Synonyma:
- Carboxyatractyloside-RM;4-CARBOXY-ATRACTYLOSIDE;Potassium carboxyatractyloside;Dipotassium carboxyatractyloside;Carboxyatractyloside dipotassium;4-carboxyatractylosidedipotassiumsal;15α-Hydroxy-2β-[[2-O-(3-methyl-1-oxobutyl)-3-O,4-O-di-(potassiooxysulfonyl)-β-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioic acid;dipotassium dihydrogen 15alpha-hydroxy-2beta-[[2-O-isovaleryl-3,4-di-O-sulphonato-beta-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioate;dipotassium dihydrogen 15alpha-hydroxy-2beta-[[2-O-isovaleryl-3,4-di-O-sulphonato-beta-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioate;Kaur-16-ene-18,19-dioic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, dipotassium salt, (2β,15α)-
- CBNumber:
- CB1893234
- Summenformel:
- C31H47KO18S2
- Molgewicht:
- 810.92
- MOL-Datei:
- 33286-30-5.mol
|
Dikaliumdihydrogen-15α-hydroxy-2β-[[2-O-isovaleryl-3,4-di-O-sulfonato-β-D-glucopyranosyl]oxy]kaur-16-en-18,19-dioat Eigenschaften
- Aggregatzustand
- Solid
- Farbe
- White to off-white
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
|
|
Sicherheit |
P261 |
Einatmen von Staub vermeiden. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
Dikaliumdihydrogen-15α-hydroxy-2β-[[2-O-isovaleryl-3,4-di-O-sulfonato-β-D-glucopyranosyl]oxy]kaur-16-en-18,19-dioat Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Carboxyatractyloside is a derivative of Atractyloside (A794530), a specific inhibitor of the adenine nucleotide translocase (ANT), which is a mitochondrial ADP/ATP carrier. It is also a proapoptotic ligand of ANT that induces pore formation by ANT, and results in permeabilization of the mitochondria membrane. Studies on rat hearts suggest that Atractyloside inhibits chloride channels from the mitochondrial membrane.
Dikaliumdihydrogen-15α-hydroxy-2β-[[2-O-isovaleryl-3,4-di-O-sulfonato-β-D-glucopyranosyl]oxy]kaur-16-en-18,19-dioat Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Dikaliumdihydrogen-15α-hydroxy-2β-[[2-O-isovaleryl-3,4-di-O-sulfonato-β-D-glucopyranosyl]oxy]kaur-16-en-18,19-dioat Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 59)Lieferanten
33286-30-5(Dikaliumdihydrogen-15α-hydroxy-2β-[[2-O-isovaleryl-3,4-di-O-sulfonato-β-D-glucopyranosyl]oxy]kaur-16-en-18,19-dioat)Verwandte Suche:
- dipotassium dihydrogen 15alpha-hydroxy-2beta-[[2-O-isovaleryl-3,4-di-O-sulphonato-beta-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioate
- 4-CARBOXY-ATRACTYLOSIDE
- 15α-Hydroxy-2β-[[2-O-(3-methyl-1-oxobutyl)-3-O,4-O-di-(potassiooxysulfonyl)-β-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioic acid
- Dipotassium carboxyatractyloside
- Potassium carboxyatractyloside
- Carboxyatractyloside dipotassium
- 4-carboxyatractylosidedipotassiumsal
- (2S,4aS,6aR,7S,9R,11aS,11bS)-7-Hydroxy-2-(((2R,3R,4R,5R,6R)-6-(hydroxymethyl)-3-((3-methylbutanoyl)oxy)-4,5-bis(sulfooxy)tetrahydro-2H-pyran-2-yl)oxy)-11b-methyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalene-4,4(4aH)-dicarboxylic acid dipotassium salt
- (2S,4aS,6aR,7S,9R,11aS,11bS)-7-Hydroxy-2-(((2R,3R,4R,5R,6R)-6-(hydroxymethyl)-3-((3-methylbutanoyl)oxy)-4,5-bis(sulfooxy)tetrahydro-2H-pyran-2-yl)oxy)-11b-methyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalene-4,4(4aH)-dicarboxylic acid dipota
- dipotassium dihydrogen 15alpha-hydroxy-2beta-[[2-O-isovaleryl-3,4-di-O-sulphonato-beta-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioate
- Carboxyatractyloside-RM
- Kaur-16-ene-18,19-dioic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, dipotassium salt, (2β,15α)-
- 33286-30-5
- C31H44O18S22K
- reagent
- standard substance